These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 15498866)
1. The PRV-1 gene expression in essential thrombocythemia. Teofili L; Martini M; Guidi F; Venditti D; Leone G; Larocca ML Blood; 2004 Nov; 104(9):2995-6. PubMed ID: 15498866 [No Abstract] [Full Text] [Related]
2. PRV-1 and its correlation with treatments and disease status in 210 patients with polycythemia vera and essential thrombocythemia. Passamonti F; Pietra D; Rumi E; Arcaini L; Della Porta MG; Malcovati L; Pascutto C; Lazzarino M; Cazzola M Leukemia; 2005 May; 19(5):888-9. PubMed ID: 15744342 [No Abstract] [Full Text] [Related]
3. Overexpression of PRV-1 gene in polycythemia rubra vera and essential thrombocythemia. Martini M; Teofili L; Larocca LM Methods Mol Med; 2006; 125():265-73. PubMed ID: 16502591 [TBL] [Abstract][Full Text] [Related]
4. Current evaluation of the clinical, diagnostic, and therapeutic usefulness of prv-1 and c-mpl markers in polycythemia vera and essential thrombocythemia. Pahl HL Clin Adv Hematol Oncol; 2004 Apr; 2(4):202, 204. PubMed ID: 16163180 [No Abstract] [Full Text] [Related]
5. The effects of hydroxyurea on PRV-1 expression in patients with essential thrombocythemia and polycythemia vera. Johansson P; Ricksten A; Wasslavik C; Johansson B; Andréasson B Haematologica; 2004 Oct; 89(10):1264-6. PubMed ID: 15477215 [TBL] [Abstract][Full Text] [Related]
6. PRV-1 mRNA expression discriminates two types of essential thrombocythemia. Griesshammer M; Klippel S; Strunck E; Temerinac S; Mohr U; Heimpel H; Pahl HL Ann Hematol; 2004 Jun; 83(6):364-70. PubMed ID: 15034760 [TBL] [Abstract][Full Text] [Related]
7. Childhood polycythemia vera and essential thrombocythemia: does their pathogenesis overlap with that of adult patients? Teofili L; Foà R; Giona F; Larocca LM Haematologica; 2008 Feb; 93(2):169-72. PubMed ID: 18245648 [No Abstract] [Full Text] [Related]
8. Overexpression of the polycythemia rubra vera-1 gene in essential thrombocythemia. Teofili L; Martini M; Luongo M; Di Mario A; Leone G; De Stefano V; Larocca LM J Clin Oncol; 2002 Oct; 20(20):4249-54. PubMed ID: 12377969 [TBL] [Abstract][Full Text] [Related]
9. Markers of myeloproliferative diseases in childhood polycythemia vera and essential thrombocythemia. Teofili L; Giona F; Martini M; Cenci T; Guidi F; Torti L; Palumbo G; Amendola A; Foà R; Larocca LM J Clin Oncol; 2007 Mar; 25(9):1048-53. PubMed ID: 17369568 [TBL] [Abstract][Full Text] [Related]
10. Epigenetic control of PRV-1 expression on neutrophils. Jelinek J; Li J; Mnjoyan Z; Issa JP; Prchal JT; Afshar-Kharghan V Exp Hematol; 2007 Nov; 35(11):1677-83. PubMed ID: 17976520 [TBL] [Abstract][Full Text] [Related]
11. Usefulness of the quantitative assessment of PRV-1 gene expression for the diagnosis of polycythemia vera and essential thrombocythemia patients. Cilloni D; Carturan S; Gottardi E; Messa F; Fava M; Defilippi I; Arruga F; Saglio G Blood; 2004 Mar; 103(6):2428; author reply 2429. PubMed ID: 14998918 [No Abstract] [Full Text] [Related]
12. JAK2 V617F mutation and PRV-1 overexpression: relevance in the diagnosis of polycythaemia vera and essential thrombocythaemia. Melis S; Vellinga S; Zachée P; Sierens AC; De Schouwer PJ Acta Clin Belg; 2009; 64(5):429-33. PubMed ID: 19999391 [TBL] [Abstract][Full Text] [Related]
13. Increased risk for vascular complications in PRV-1 positive patients with essential thrombocythaemia. Johansson P; Ricksten A; Wennström L; Palmqvist L; Kutti J; Andréasson B Br J Haematol; 2003 Nov; 123(3):513-6. PubMed ID: 14617016 [TBL] [Abstract][Full Text] [Related]
14. Frequency and clinical features of the JAK2 V617F mutation in pediatric patients with sporadic essential thrombocythemia. Nakatani T; Imamura T; Ishida H; Wakaizumi K; Yamamoto T; Otabe O; Ishigami T; Adachi S; Morimoto A Pediatr Blood Cancer; 2008 Dec; 51(6):802-5. PubMed ID: 18802948 [TBL] [Abstract][Full Text] [Related]
15. Endogenous erythroid and megakaryocytic circulating progenitors, HUMARA clonality assay, and PRV-1 expression are useful tools for diagnosis of polycythemia vera and essential thrombocythemia. Florensa L; Besses C; Zamora L; Bellosillo B; Espinet B; Serrano S; Woessner S; Solé F Blood; 2004 Mar; 103(6):2427-8. PubMed ID: 14998917 [No Abstract] [Full Text] [Related]
16. Thrombotic and bleeding complications in four subpopulations of patients with essential thrombocythemia defined by c-Mpl protein expression and PRV-1 mRNA levels. Goerttler PL; März E; Johansson PL; Andreasson B; Kutti J; Moliterno AR; Marchioli R; Spivak JL; Pahl HL; Haematologica; 2005 Jun; 90(6):851-3. PubMed ID: 15951300 [TBL] [Abstract][Full Text] [Related]
17. Detection of abnormalities of PRV-1, TPO, and c-MPL genes detected by fluorescence in situ hybridization in essential thrombocythemia. Puigdecanet E; Espinet B; Villa O; Florensa L; Besses C; Serrano S; Solé F Cancer Genet Cytogenet; 2006 May; 167(1):39-42. PubMed ID: 16682284 [TBL] [Abstract][Full Text] [Related]